303 related articles for article (PubMed ID: 27578012)
1. Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.
Lu LN; Qian ZM; Wu KC; Yung WH; Ke Y
Mol Neurobiol; 2017 Sep; 54(7):5213-5224. PubMed ID: 27578012
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats.
Du F; Qian ZM; Luo Q; Yung WH; Ke Y
Mol Neurobiol; 2015 Aug; 52(1):101-14. PubMed ID: 25115800
[TBL] [Abstract][Full Text] [Related]
3. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells.
Urrutia P; Aguirre P; Esparza A; Tapia V; Mena NP; Arredondo M; González-Billault C; Núñez MT
J Neurochem; 2013 Aug; 126(4):541-9. PubMed ID: 23506423
[TBL] [Abstract][Full Text] [Related]
4. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
[TBL] [Abstract][Full Text] [Related]
5. The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease.
Raha AA; Vaishnav RA; Friedland RP; Bomford A; Raha-Chowdhury R
Acta Neuropathol Commun; 2013 Sep; 1():55. PubMed ID: 24252754
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent expression of duodenal cytochrome b, divalent metal transporter 1, ferroportin 1, and hephaestin in the duodenum of rats.
Kong WN; Wu Q; Shen D; Zhao SE; Guo P; Duan XL; Chang YZ
J Gastroenterol Hepatol; 2015 Mar; 30(3):513-20. PubMed ID: 25318588
[TBL] [Abstract][Full Text] [Related]
7. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.
Thompson K; Menzies S; Muckenthaler M; Torti FM; Wood T; Torti SV; Hentze MW; Beard J; Connor J
J Neurosci Res; 2003 Jan; 71(1):46-63. PubMed ID: 12478613
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin treatment modulates the expression of divalent metal transporter-1, ceruloplasmin, and ferroportin-1 in the rat cerebral cortex and hippocampus.
Li L; Holscher C; Chen BB; Zhang ZF; Liu YZ
Biol Trace Elem Res; 2011 Dec; 143(3):1581-93. PubMed ID: 21274654
[TBL] [Abstract][Full Text] [Related]
9. Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis?
Hofer T; Perry G
J Trace Elem Med Biol; 2016 Dec; 38():1-9. PubMed ID: 27329321
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II inhibits uptake of transferrin-bound iron but not non-transferrin-bound iron by cultured astrocytes.
Huang S; Du F; Li L; Liu Y; Liu Y; Zhang C; Qian ZM
Neuropeptides; 2014 Jun; 48(3):161-6. PubMed ID: 24786977
[TBL] [Abstract][Full Text] [Related]
11. Sub-lethal levels of amyloid β-peptide oligomers decrease non-transferrin-bound iron uptake and do not potentiate iron toxicity in primary hippocampal neurons.
SanMartín CD; Paula-Lima AC; Hidalgo C; Núñez MT
Biometals; 2012 Aug; 25(4):805-13. PubMed ID: 22526560
[TBL] [Abstract][Full Text] [Related]
12. Pro-inflammatory cytokines modulate iron regulatory protein 1 expression and iron transportation through reactive oxygen/nitrogen species production in ventral mesencephalic neurons.
Wang J; Song N; Jiang H; Wang J; Xie J
Biochim Biophys Acta; 2013 May; 1832(5):618-25. PubMed ID: 23376588
[TBL] [Abstract][Full Text] [Related]
13. Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease.
Yu X; Du T; Song N; He Q; Shen Y; Jiang H; Xie J
Neurology; 2013 Jan; 80(5):492-5. PubMed ID: 23303856
[TBL] [Abstract][Full Text] [Related]
14. Aspirin increases ferroportin 1 expression by inhibiting hepcidin via the JAK/STAT3 pathway in interleukin 6-treated PC-12 cells.
Huang SN; Ruan HZ; Chen MY; Zhou G; Qian ZM
Neurosci Lett; 2018 Jan; 662():1-5. PubMed ID: 28987816
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor protects PC12 cells against OGD/R-induced injury by reducing iron.
Li S; Qian ZM; Xu G; Zheng J; Wu Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32186328
[TBL] [Abstract][Full Text] [Related]
16. Ferroportin1 in the brain.
Qian ZM; Li W; Guo Q
Ageing Res Rev; 2023 Jul; 88():101961. PubMed ID: 37236369
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin Promoted Ferroptosis through Iron Metabolism which Is Associated with DMT1 Signaling Activation in Early Brain Injury following Subarachnoid Hemorrhage.
Zhang H; Ostrowski R; Jiang D; Zhao Q; Liang Y; Che X; Zhao J; Xiang X; Qin W; He Z
Oxid Med Cell Longev; 2021; 2021():9800794. PubMed ID: 34987706
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMP-protein kinase A pathway.
Du F; Qian C; Qian ZM; Wu XM; Xie H; Yung WH; Ke Y
Glia; 2011 Jun; 59(6):936-45. PubMed ID: 21438013
[TBL] [Abstract][Full Text] [Related]
19. Changes of ferrous iron and its transporters after intracerebral hemorrhage in rats.
Wang G; Shao A; Hu W; Xue F; Zhao H; Jin X; Li G; Sun Z; Wang L
Int J Clin Exp Pathol; 2015; 8(9):10671-9. PubMed ID: 26617777
[TBL] [Abstract][Full Text] [Related]
20. [Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice].
Jiang H; Qian ZM; Xie JX
Sheng Li Xue Bao; 2003 Oct; 55(5):571-6. PubMed ID: 14566406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
